ANIXA BIOSCIENCES, INC. Retained Earnings
ANIXA BIOSCIENCES, INC. (ANIX) had Retained Earnings of -$259.36 million as of 2026-07-31, per its 10-Q filed 2026-09-09.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-09-09
- 2026-07-31: Retained Earnings (Accumulated Deficit) -$259.36M.
- 2026-04-30: Retained Earnings (Accumulated Deficit) -$256.76M.
- 2026-01-31: Retained Earnings (Accumulated Deficit) -$254.24M.
- 2025-10-31: Retained Earnings (Accumulated Deficit) -$251.68M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-07-31 | -$259.36M 10-Q · filed 2026-09-09 | |
| 2026-04-30 | -$256.76M 10-Q · filed 2026-06-10 | |
| 2026-01-31 | -$254.24M 10-Q · filed 2026-03-09 | |
| 2025-10-31 | -$251.68M 10-Q · filed 2026-09-09 | |
| 2025-07-31 | -$248.98M 10-Q · filed 2025-09-10 | |
| 2025-04-30 | -$246.72M 10-Q · filed 2025-05-28 | |
| 2025-01-31 | -$243.93M 10-Q · filed 2025-03-11 | |
| 2024-10-31 | -$240.75M 10-K · filed 2026-01-12 | |
| 2024-07-31 | -$237.87M 10-Q · filed 2024-09-06 | |
| 2024-04-30 | -$234.59M 10-Q · filed 2024-06-04 | |
| 2024-01-31 | -$231.45M 10-Q · filed 2024-03-12 | |
| 2023-10-31 | -$228.20M 10-K · filed 2025-01-10 | |
| 2023-07-31 | -$225.51M 10-Q · filed 2023-09-06 | |
| 2023-04-30 | -$223.00M 10-Q · filed 2023-06-14 | |
| 2023-01-31 | -$220.71M 10-Q · filed 2023-03-17 | |
| 2022-10-31 | -$218.38M 10-K · filed 2024-01-16 | |
| 2022-07-31 | -$214.91M 10-Q · filed 2022-09-09 | |
| 2022-04-30 | -$212.16M 10-Q · filed 2022-06-10 | |
| 2022-01-31 | -$208.62M 10-Q · filed 2022-03-11 | |
| 2021-10-31 | -$204.79M 10-K · filed 2023-01-04 | -$204.79M 10-K · filed 2022-01-04 |
| 2021-07-31 | -$200.78M 10-Q · filed 2021-09-01 | |
| 2021-04-30 | -$196.44M 10-Q · filed 2021-06-10 | |
| 2021-01-31 | -$194.04M 10-Q · filed 2021-03-11 | |
| 2020-10-31 | -$191.84M 10-K · filed 2022-01-04 | |
| 2020-07-31 | -$189.61M 10-Q · filed 2020-09-08 | |
| 2020-04-30 | -$187.05M 10-Q · filed 2020-06-09 | |
| 2020-01-31 | -$184.41M 10-Q · filed 2020-03-09 | |
| 2019-10-31 | -$181.82M 10-K · filed 2021-01-07 | |
| 2019-07-31 | -$179.73M 10-Q · filed 2019-09-06 | |
| 2019-04-30 | -$177.59M 10-Q · filed 2019-06-12 | |
| 2019-01-31 | -$175.05M 10-Q · filed 2019-03-13 | |
| 2018-10-31 | -$170.17M 10-K · filed 2020-01-09 | |
| 2018-07-31 | -$164.87M 10-Q · filed 2018-09-07 | |
| 2018-04-30 | -$159.39M 10-Q · filed 2018-06-11 | |
| 2018-01-31 | -$158.01M 10-Q · filed 2018-03-09 | |
| 2017-10-31 | -$156.17M 10-K · filed 2019-01-11 | |
| 2017-07-31 | -$154.39M 10-Q · filed 2017-09-08 | |
| 2017-04-30 | -$152.59M 10-Q · filed 2017-05-26 | |
| 2017-01-31 | -$152.75M 10-Q · filed 2017-03-16 | |
| 2016-10-31 | -$151.17M 10-K · filed 2018-01-09 | |
| 2016-07-31 | -$150.12M 10-Q · filed 2016-08-19 | |
| 2016-04-30 | -$149.01M 10-Q · filed 2016-05-20 | |
| 2016-01-31 | -$147.74M 10-Q · filed 2016-02-19 | |
| 2015-10-31 | -$146.15M 10-K · filed 2016-12-08 | |
| 2015-07-31 | -$144.86M 10-Q · filed 2015-08-18 | |
| 2015-04-30 | -$143.25M 10-Q · filed 2015-05-22 | |
| 2015-01-31 | -$141.02M 10-Q · filed 2015-03-09 | |
| 2014-10-31 | -$144.77M 10-K · filed 2015-12-23 | |
| 2014-07-31 | -$141.62M 10-Q · filed 2014-09-15 | |
| 2014-04-30 | -$142.03M 10-Q · filed 2014-06-16 | |
| 2014-01-31 | -$138.78M 10-Q · filed 2014-03-17 | |
| 2013-10-31 | -$135.16M 10-K · filed 2015-01-29 | |
| 2013-07-31 | -$132.24M 10-Q/A · filed 2013-09-20 | |
| 2013-04-30 | -$129.65M 10-Q/A · filed 2013-06-19 | |
| 2013-01-31 | -$127.18M 10-Q/A · filed 2013-03-25 | |
| 2012-10-31 | -$125.08M 10-K/A · filed 2014-01-17 | |
| 2012-07-31 | -$123.22M 10-Q · filed 2012-09-14 | |
| 2012-04-30 | -$122.59M 10-Q · filed 2012-06-14 | |
| 2012-01-31 | -$121.72M 10-Q · filed 2012-03-16 | |
| 2011-10-31 | -$120.83M 10-K · filed 2013-01-29 | |
| 2011-07-31 | -$118.04M 10-Q/A · filed 2011-10-14 | |
| 2010-10-31 | -$113.45M 10-K · filed 2012-01-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 |